These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 9469843)
21. Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae. Hofmann KJ; Neeper MP; Markus HZ; Brown DR; Müller M; Jansen KU J Gen Virol; 1996 Mar; 77 ( Pt 3)():465-8. PubMed ID: 8601783 [TBL] [Abstract][Full Text] [Related]
22. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Zhou J; Sun XY; Stenzel DJ; Frazer IH Virology; 1991 Nov; 185(1):251-7. PubMed ID: 1656586 [TBL] [Abstract][Full Text] [Related]
23. Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody. Liu DW; Chang JL; Tsao YP; Huang CW; Kuo SW; Chen SL Int J Cancer; 2005 Jan; 113(1):93-100. PubMed ID: 15386434 [TBL] [Abstract][Full Text] [Related]
24. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer. Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172 [TBL] [Abstract][Full Text] [Related]
26. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus. Le Cann P; Touze A; Enogat N; Leboulleux D; Mougin C; Legrand MC; Calvet C; Afoutou JM; Coursaget P J Clin Microbiol; 1995 May; 33(5):1380-2. PubMed ID: 7615761 [TBL] [Abstract][Full Text] [Related]
27. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Chen XS; Garcea RL; Goldberg I; Casini G; Harrison SC Mol Cell; 2000 Mar; 5(3):557-67. PubMed ID: 10882140 [TBL] [Abstract][Full Text] [Related]
28. Construction and immunogenicity of human papillomavirus type 6b L1 recombinant plasmid. Liu F; Wang JB; Zuo YG; Liu YH; Ma DL Chin Med Sci J; 2004 Sep; 19(3):233-6. PubMed ID: 15506656 [TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus 16 minor capsid protein L2 helps capsomeres assemble independently of intercapsomeric disulfide bonding. Ishii Y; Ozaki S; Tanaka K; Kanda T Virus Genes; 2005 Dec; 31(3):321-8. PubMed ID: 16175337 [TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Matić S; Masenga V; Poli A; Rinaldi R; Milne RG; Vecchiati M; Noris E Plant Biotechnol J; 2012 May; 10(4):410-21. PubMed ID: 22260326 [TBL] [Abstract][Full Text] [Related]
31. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. Christensen ND; Höpfl R; DiAngelo SL; Cladel NM; Patrick SD; Welsh PA; Budgeon LR; Reed CA; Kreider JW J Gen Virol; 1994 Sep; 75 ( Pt 9)():2271-6. PubMed ID: 7521393 [TBL] [Abstract][Full Text] [Related]
32. Infectious human papillomavirus type 18 pseudovirions. Stauffer Y; Raj K; Masternak K; Beard P J Mol Biol; 1998 Oct; 283(3):529-36. PubMed ID: 9784363 [TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. Malboeuf CM; Simon DA; Lee YE; Lankes HA; Dewhurst S; Frelinger JG; Rose RC Vaccine; 2007 Apr; 25(17):3270-6. PubMed ID: 17293010 [TBL] [Abstract][Full Text] [Related]
35. Baculovirus expression of the human papillomavirus type 16 capsid proteins: detection of L1-L2 protein complexes. Xi SZ; Banks LM J Gen Virol; 1991 Dec; 72 ( Pt 12)():2981-8. PubMed ID: 1662690 [TBL] [Abstract][Full Text] [Related]
36. Production of SV40 proteins in insect cells and in vitro packaging of virions and pseudovirions. Sandalon Z; Oppenheim A Methods Mol Biol; 2001; 165():119-28. PubMed ID: 11217381 [No Abstract] [Full Text] [Related]
37. Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Varsani A; Williamson AL; Rose RC; Jaffer M; Rybicki EP Arch Virol; 2003 Sep; 148(9):1771-86. PubMed ID: 14505089 [TBL] [Abstract][Full Text] [Related]
38. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins]. Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206 [TBL] [Abstract][Full Text] [Related]
39. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae. Cook JC; Joyce JG; George HA; Schultz LD; Hurni WM; Jansen KU; Hepler RW; Ip C; Lowe RS; Keller PM; Lehman ED Protein Expr Purif; 1999 Dec; 17(3):477-84. PubMed ID: 10600468 [TBL] [Abstract][Full Text] [Related]
40. The nine C-terminal amino acids of the major capsid protein of the human papillomavirus type 16 are essential for DNA binding and gene transfer capacity. Touzé A; Mahé D; El Mehdaoui S; Dupuy C; Combita-Rojas AL; Bousarghin L; Sizaret PY; Coursaget P FEMS Microbiol Lett; 2000 Aug; 189(1):121-7. PubMed ID: 10913877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]